Reason: Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Distributed: USA nationwideReason: Marketed Without an Approved NDA/ANDA; products have been found to contain tadalafil, the active ingredient in an FDA approved product used to treat erectile dysfunction, making this product an unapproved drug
Distributed: US states nationwide and international.Reason: Marketed Without an Approved NDA/ANDA; products have been found to contain tadalafil, the active ingredient in an FDA approved product used to treat erectile dysfunction, making this product an unapproved drug
Distributed: US states nationwide and international.Reason: Lack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer.
Distributed: NationwideReason: Lack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.
Distributed: Nationwide and Puerto RicoReason: Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.
Distributed: NaitonwideReason: Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.
Distributed: NationwideReason: Failed Tablet/Capsule Specification: Teva is recalling certain lots of Propanolol HCl Tablets, 10 mg due to the potential of some tablets not conforming to weight specification.
Distributed: NationwideReason: Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for the epinephrine component.
Distributed: Nationwide and CanadaReason: Presence of Particulate Matter; product may contain fibrous material
Distributed: Nationwide